CN107549182A - A kind of antiviral composition containing Portugal's polyene sugar - Google Patents

A kind of antiviral composition containing Portugal's polyene sugar Download PDF

Info

Publication number
CN107549182A
CN107549182A CN201710915949.8A CN201710915949A CN107549182A CN 107549182 A CN107549182 A CN 107549182A CN 201710915949 A CN201710915949 A CN 201710915949A CN 107549182 A CN107549182 A CN 107549182A
Authority
CN
China
Prior art keywords
portugal
antiviral composition
polyene
disease
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710915949.8A
Other languages
Chinese (zh)
Inventor
许兴志
韦能春
王成
邓晓杰
赵艳龙
王宗
张宗英
张元珍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jingbo Agrochemicals Technology Co Ltd
Original Assignee
Jingbo Agrochemicals Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jingbo Agrochemicals Technology Co Ltd filed Critical Jingbo Agrochemicals Technology Co Ltd
Priority to CN201710915949.8A priority Critical patent/CN107549182A/en
Publication of CN107549182A publication Critical patent/CN107549182A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to technical field of pesticide combination, more particularly to a kind of antiviral composition containing Portugal's polyene sugar, the antiviral composition includes active ingredient and auxiliary element, wherein active ingredient is component A and Portugal's polyene sugar, percetage by weight of the active ingredient in antiviral composition is 1% 80%, and described component A is tetrahydro-beta-carboline alcaloid-derivatives.Antiviral composition of the present invention is used to prevent and treat brassicaceous vegetable virosis or rugose mosaic virus of potato or camellia mosaic disease or peanut stunt or tomato virus disease or graw mold of tomato.The present invention improves prevention effect, reduces residues of pesticides and environmental pollution using Portugal's polyene sugar and component A as active ingredient, is advantageous to avoid virus resistance from producing and delay the generation speed of viral resistance.

Description

A kind of antiviral composition containing Portugal's polyene sugar
Technical field
The present invention relates to technical field of pesticide combination, more particularly to a kind of antiviral composition containing Portugal's polyene sugar.
Background technology
The viroses of plant worldwide constitute a serious threat to Crop yield and quality, it is annual caused by the underproduction reach 10-30%, economic loss are about 20,000,000,000 dollars.Its is widely distributed, and species is various, and route of transmission is wide, and harm is serious.Phytopathy The prevention and controls of viral disease mainly have:1) breeding resistant variety, seed or trophosome detoxification, utilize low virulent strain system and satellite RNA;2) Biocidal wash passes virus mediator;3) adjust date of seeding, improve cropping system etc.;4) Agro-chemicals control.To promote disease-resistant variety in The comprehensive preventive health measures of the heart is a kind of precautionary measures, and there is no preferable disease-resistant variety at present, lacks effectively preventing medicament It is viroses of plant wide-scale distribution, the principal element of large area sprawling.
Portugal's polyene sugar, is a kind of international new bio inductivity virucide newly developed, and activity is significantly higher than common widow Sugar product, crop system can be induced to obtain the motivating factor of disease resistance, show distinctive biological activity:On the one hand, can lure The disease resistance that crop produces excellent broad spectrum is led, for virosis, can not only suppress the early stage of the multiple diseases such as mosaic virus Colonize, breed and extend, and the external virus original of crop can also be passivated, suppress the long range extension of virus.Simultaneously as work Thing growth regulator, moreover it is possible to promote crop cell activation, stimulating growth.It can also promote photosynthesis using Portugal's polyene sugar, increase Sugared part and the accumulation of vitamin, improve crop autoimmunity and defense response.Strengthen the resistance of crop, effectively facilitate crop Growth, branch, bloom, result etc..Crop carry out Portugal's polyene sugar spray processing after, viral time of occurrence is suitable in newborn blade Evening, and occurring degree is very low.For other diseases, such as celery wilt disease, cucumber samping off, root rot, tomato disease Viral disease, graw mold of tomato also have significant prevention effect.
Component A, its primary structure have (1S, 3S)-N '-(4- chlorobenzenes methylene) -1- methyl -2,3,4,9- tetrahydropyridines And [3,4-b] indoles -3- formylhydrazines (Formulas I) and (1S, 3S)-N '-(cyclohexylmethylene) -1- methyl -2,3,4,9- tetrahydrochysene pyrroles Pyridine simultaneously [3,4-b] indoles -3- formylhydrazines (Formula II).Tested by toxicity, it is found that it is very excellent antiviral the compound has Characteristic.There is certain stimulation to plant growth.Also there is good therapeutic action simultaneously for the crop to have fallen ill.
At present, the compounded technology of Portugal's polyene sugar and component A has not been reported.
The content of the invention
Current viral diseases agricultural chemicals widely used in production, it is mostly Moroxydine Hydrochloride, amino widow on formula composition The single dose of sugared element, Portugal's polyene sugar etc. or the mixture with zinc sulfate, copper sulphate, copper acetate, the basic element of cell division etc., it is in premorbid Preferable using preventive effect, the therapeutic effect applied after morbidity is poor.In view of what compound A was shown in actual screening process There is good therapeutic action to the virosis caused by virus, with reference to biological inducer Portugal polyene sugar, accomplish that preventing and treating combines, solve Refractory problem can be prevented in agricultural production.
For the foregoing reasons, the invention provides a kind of using antiviral compound of polyene sugar in Portugal's with component A as active ingredient Thing, described antiviral composition is using Portugal's polyene sugar and component A as active ingredient, the percentage by weight of active ingredient in composition For 1-80%, Portugal's polyene sugar and component A weight ratio are 50:1-1:40.Preferable proportion of composing is 5:1-1:10.Described group It is tetrahydro-beta-carboline alcaloid-derivatives to divide A.
The formulation of described antiviral composition is missible oil or suspending agent or ultra low volume liquids or aqueous emulsion or microemulsion Or water-dispersible granules.
When stating formulation in the choice, the auxiliary element in described antiviral composition is selected from emulsifying agent or solvent or scattered One or more in agent or wetting agent or disintegrant or thickener or stabilizer or defoamer or filler.
The emulsifying agent is calcium dodecyl benzene sulfonate, OPEO sodium sulphate, OPEO Sodium sulphate Succinate sodium sulfonate, alkylphenol-polyethenoxy base phosphate, neopelex, dodecyl polyoxyethylene In ether, fatty alcohol-ether sodium sulfate phosphate, polyoxyethylene aliphatic alcohol ether, succinic acid dialkyl sulfoacid calcium and fatty alcohol-ether sodium sulfate One or more;
The solvent be dimethylbenzene, diesel oil, heavy aromatics, cyclohexanol, aromatic hydrocarbons S-150, aromatic hydrocarbons 200#, soybean oil, turpentine oil, Methyl oleate, castor oil methyl esters, cyclohexanone, ethanol, 1-METHYLPYRROLIDONE, ethyl acetate and one kind or more in aqueous solvent Kind;
The wetting agent be lauryl sodium sulfate, calcium dodecyl benzene sulfonate, aliphatic alcohol polyethenoxy base ether sodium sulfate, One or more in Negel, alkylphenol-polyethenoxy base ether phosphoric acid sodium and spaonin powder;
The dispersant is sodium lignin sulfonate, ammonium lignosulphonate, alkylphenol-polyethenoxy base ether sulfonic acid sodium, alkylbenzene One or more in sulfonic acid calcium salt, sodium alkyl benzene sulfonate and glycerin polyoxyethylene ether fatty ester;
The antifreezing agent is the one or more in ethylene glycol, propane diols, glycerine and urea;
The thickener is the one or more in xanthans, Magnesiumaluminumsilicate, hydroxymethyl cellulose and Sodium Polyacrylate;
The defoamer is the one or more in silicone oil, organic silicone and polypropylene glycerol aether;
The disintegrant is the one or more in bentonite, ammonium sulfate, sodium acid carbonate, aluminium chloride and succinic acid;
The filler is the one or more in white carbon, kaolin, diatomite, precipitated calcium carbonate and starch.
Specific visual formulation difference carries out selection combination.
Antiviral composition of the present invention is applied to by Brassica 2 et 4 (abbreviation TuMV), cucumber mosaic virus (letter Claim CMV), brassicaceous vegetable virosis caused by tobacco mosaic virus (TMV) (abbreviation TMV), while to potato virus X (PVX), Rugose mosaic virus of potato caused by marmor upsilon (PVY), while to camellia mosaic disease, peanut stunt, tomato virus Disease, graw mold of tomato also have preferable prevention effect.
In order to determine the optimum amount ratio of Portugal's polyene sugar and component A, Portugal's polyene sugar and component A are pressed constant weight by inventor Than being compounded, its weight ratio be 50/1,40/1,30/1,20/1,10/1,5/1,1/1,1/3,1/5,1/10,1/20,1/30, 1/40, respectively using the solvable pulvis (commercially available product) of 0.5% Portugal polyene sugar and 1% component A wettable powders (making in laboratory) as Control carries out spraying verification the verifying results to tobacco mosaic disease and rugose mosaic virus of potato respectively.
Major experimental object is handled in the following manner, is gathered virosis blade from field, is carried with 0.1M phosphate buffer Viral juice is taken, then with juice rubbing manipulation virus inoculation disease.After inoculation 2 days, docking plant carries out spray processing.Interval 7 It is sprayed once, is sprayed 2 times altogether.After first time dispenser 7 days after 7 days and second of dispenser, that investigates each processing prevents effect.Disease Feelings grade scale is as follows:
0 grade:Complete stool is disease-free;1 grade:The bright arteries and veins of blade and slight flower leaf paresthesia;3 grades:Blade has obvious flower leaf paresthesia;5 grades: Blade has heavy flower leaf paresthesia, shrinkage, and plant is slightly downgraded (less than 1/3);7 grades:Blade weight floral leaf, narrows, plant is substantially downgraded (1/3-2/3), petiole base have mild necrosis streak;9 grades:Leaf malformation, plant seriously downgrade (more than 2/3), base portion or life Long point necrosis or complete stool are withered.
(I) and (II) calculates preventive effect as follows:
(I)
(II)
Experiment shows higher to the average preventive effect of peanut stunt in 5/1 ratio, reaches 96.6%, to camellia mosaic disease There is 93.7% control rate.Obvious effect is shown than single dose.Have in 1/10 ratio to tomato virus disease good Preventive effect, reach 95.3%, 93.2% preventive effect has also been reached to tobacco mosaic virus (TMV).Compared to 0.5% Portugal's polyene of exclusive use The 68.3% of the solvable pulvis of sugar is obviously improved.
In summary, technical scheme provided by the invention is using antiviral compound of polyene sugar in Portugal's with component A as active ingredient Thing, both mixtures using single medicine substantially than having synergistic effect.The dosage of chemical pesticide so can be not only reduced, is adapted to existing The pesticide reduction policy requirements that stage proposes, while the cost of Pesticide use can be reduced, improve preventive effect.
The present invention is using Portugal's polyene sugar and component A as active ingredient, and both mixtures using single medicine substantially than having synergy work With improving prevention effect;Simultaneously as drug effect improves, field dosage is greatly decreased, and reduces residues of pesticides and environment is dirty Dye, production and use cost decline;In addition, the mechanism of action of active ingredient is different in antiviral composition, reduce pair The single selection pressure of virus, be advantageous to avoid virus resistance from producing and delay the generation speed of viral resistance.
Embodiment
Embodiment 1
11% Portugal's polyene saccharic composition A missible oil
Raw material forms:1% Portugal's polyene sugar, 10% component A active compounds, 5%N- methyl pyrrolidones, 3% detergent alkylate sulphur Sour calcium, 2% fatty alcohol-ether sodium sulfate phosphate, 5% phenethyl phenolformaldehyde resin APEO, remaining uses aromatic hydrocarbons S-150 Supply.Routinely the missible oil mode of production is prepared.Described component A be (1S, 3S)-N '-(4- chlorobenzenes methylene) -1- methyl - 2,3,4,9- tetrahydropyridines simultaneously [3,4-b] indoles -3- formylhydrazines.
The sample of embodiment 1, comparison medicament are the solvable pulvis (commercially available product) of 0.5% Portugal's polyene sugar and 1% component A wettable powders Agent (making in laboratory) carries out comparative efficacy test for contrast.Controlling object:Tobacco mosaic disease, tomato virus disease.
Temperature on average is at 21-25 DEG C during medication, and weather is based on fine, as shown by data:Complex preparation is prevented compared with single dose Efficiency increases.
Embodiment 2
30% Portugal's polyene saccharic composition A suspending agents
Raw material forms:20% Portugal's polyene sugar, 10% component A, 1% sodium lignin sulphate, 2% DBSA Calcium, 3% triphenoethyl benzene phenol polyethenoxy ether, the anti-alcohol APEO 1.0% of fat, 1% aluminium-magnesium silicate, 0.10% xanthans, 5% ethylene glycol, remaining is supplied with water.Routinely the suspending agent mode of production is prepared.Described component A is (1S, 3S)-N '-(ring Hexyl methylene) -1- methyl -2,3,4,9- tetrahydropyridines simultaneously [3,4-b] indoles -3- formylhydrazines.
The sample of embodiment 2, comparison medicament are the solvable pulvis (commercially available product) of 0.5% Portugal's polyene sugar and 1% component A wettable powders Agent (making in laboratory) carries out comparative efficacy test for contrast.Controlling object:Cucumber mosaic virus, rugose mosaic virus of potato.
Temperature on average is at 21-25 DEG C during medication, and weather is based on fine, as shown by data:Complex preparation is prevented compared with single dose Efficiency increases.
Embodiment 3
41% Portugal's polyene saccharic composition A wettable powders
Raw material composition is sugared for 1% Portugal's polyene, 40% component A, 1% lauryl sodium sulfate, 7% alkylphenol-polyethenoxy base Ether sulfonic acid sodium, 2% sodium lignin sulfonate, 3.5% lignin sulfonic acid dipersant, remaining is supplied with precipitated calcium carbonate.Routinely Can the preparation of the wet-milling mode of production.Described component A is (1S, 3S)-N '-(cyclohexylmethylene) -1- methyl -2,3,4,9- tetrahydrochysenes Pyrido [3,4-b] indoles -3- formylhydrazines.
The sample of embodiment 3, comparison medicament are the solvable pulvis (commercially available product) of 0.5% Portugal's polyene sugar and 1% component A wettable powders Agent (making in laboratory) carries out comparative efficacy test for contrast.Controlling object:Turnip mosaic virus, rugose mosaic virus of potato.
Temperature on average is at 21-25 DEG C during medication, and weather is based on fine, as shown by data:Complex preparation is prevented compared with single dose Efficiency increases.
Embodiment 4
5.1% Portugal's polyene saccharic composition A ultra low volume liquids
Raw material composition is sugared for 5% Portugal's polyene, 0.1% component A, 3% AEO, 5% alkylaryl polyoxy Propylene APEO, 10% n-octyl alcohol, remaining is supplied with butyl benzene.Routinely the missible oil mode of production is prepared.Described component A For (1S, 3S)-N '-(4- chlorobenzenes methylene) -1- methyl -2,3,4,9- tetrahydropyridines simultaneously [3,4-b] indoles -3- formylhydrazines.
The sample of embodiment 4, comparison medicament are the solvable pulvis (commercially available product) of 0.5% Portugal's polyene sugar and 1% component A wettable powders Agent (making in laboratory) carries out comparative efficacy test for contrast.Controlling object:Graw mold of tomato, Turnip mosaic virus.
Temperature on average is at 21-25 DEG C during medication, and weather is based on fine, as shown by data:Complex preparation is prevented compared with single dose Efficiency increases.
Embodiment 5
1% Portugal's polyene saccharic composition A aqueous emulsions
Raw material composition is sugared for 0.5% Portugal's polyene, 0.5% component A, 10% dimethylbenzene, and 10% alkylaryl polyoxypropylene gathers Oxygen vinethene, 5% OPEO sodium sulphate Succinate sodium sulfonate, 5% ethylene glycol remaining supplied with water.Routinely The aqueous emulsion mode of production is prepared.Described component A is (1S, 3S)-N '-(cyclohexylmethylene) -1- methyl -2,3,4,9- tetrahydrochysenes Pyrido [3,4-b] indoles -3- formylhydrazines.
The sample of embodiment 5, comparison medicament are the solvable pulvis (commercially available product) of 0.5% Portugal's polyene sugar and 1% component A wettable powders Agent (making in laboratory) carries out comparative efficacy test for contrast.Controlling object:Tobacco mosaic disease, rugose mosaic virus of potato.
Temperature on average is at 21-25 DEG C during medication, and weather is based on fine, as shown by data:Complex preparation is prevented compared with single dose Efficiency increases.
Embodiment 6
6% Portugal's polyene saccharic composition A microemulsions
Raw material composition is sugared for 5% Portugal's polyene, 1% component A, 10%N- methyl pyrrolidone, 15% polyoxyethylene fatty alcohol Ether, 10% calcium dodecyl benzene sulfonate, 10% OPEO sodium sulphate Succinate sodium sulfonate, remaining is mended with water Foot.Routinely the microemulsion mode of production is prepared.Described component A be (1S, 3S)-N '-(4- chlorobenzenes methylene) -1- methyl - 2,3,4,9- tetrahydropyridines simultaneously [3,4-b] indoles -3- formylhydrazines.
The sample of embodiment 6, comparison medicament are the solvable pulvis (commercially available product) of 0.5% Portugal's polyene sugar and 1% component A wettable powders Agent (making in laboratory) carries out comparative efficacy test for contrast.Controlling object:Camellia mosaic disease, peanut stunt.
Temperature on average is at 21-25 DEG C during medication, and weather is based on fine, as shown by data:Complex preparation is prevented compared with single dose Efficiency increases.
Embodiment 7
80% Portugal's polyene saccharic composition A microemulsions
Raw material composition is 5% Portugal polyene sugar, 75% component A, 10% polycarboxylate salt dispersant, 5% naphthalenesulfonatedispersant dispersant, Remaining is supplied with oxidised maize starch.Routinely the microemulsion mode of production is prepared.Described component A be (1S, 3S)-N '- (4- chlorobenzenes methylene) -1- methyl -2,3,4,9- tetrahydropyridines simultaneously [3,4-b] indoles -3- formylhydrazines.
Manner of formulation:Fineness and content are detected after air-flow crushing, crushing are carried out after above-mentioned each material is mixed, detection is qualified Afterwards plus water mixes, and is then granulated, dried by extrusion, detects qualified rear packing and gets product.
The sample of embodiment 7, comparison medicament are the solvable pulvis (commercially available product) of 0.5% Portugal's polyene sugar and 1% component A wettable powders Agent (making in laboratory) carries out comparative efficacy test for contrast.Controlling object:Tobacco mosaic disease, rugose mosaic virus of potato.
Temperature on average is at 21-25 DEG C during medication, and weather is based on fine, as shown by data:Complex preparation is prevented compared with single dose Efficiency increases.

Claims (6)

  1. A kind of 1. antiviral composition containing Portugal's polyene sugar, it is characterised in that:The antiviral composition includes active ingredient And auxiliary element, wherein active ingredient is component A and Portugal's polyene is sugared, percetage by weight of the active ingredient in antiviral composition For 1%-80%, described component A is tetrahydro-beta-carboline alcaloid-derivatives.
  2. A kind of 2. antiviral composition containing Portugal's polyene sugar according to claim 1, it is characterised in that:Described component A is (1S, 3S)-N '-(4- chlorobenzenes methylene) -1- methyl -2,3,4,9- tetrahydropyridines simultaneously [3,4-b] indoles -3- formylhydrazines Or (1S, 3S)-N '-(cyclohexylmethylene) -1- methyl -2,3,4,9- tetrahydropyridines simultaneously [3,4-b] indoles -3- formylhydrazines or its Mixture.
  3. A kind of 3. antiviral composition containing Portugal's polyene sugar according to claim 1, it is characterised in that:Described Portugal gathers Glycal and component A weight ratio are 50:1-1:40.
  4. A kind of 4. antiviral composition containing Portugal's polyene sugar according to claim 1, it is characterised in that:Described is disease-resistant The formulation of malicious composition is missible oil or suspending agent or ultra low volume liquids or aqueous emulsion or microemulsion or water-dispersible granules.
  5. A kind of 5. antiviral composition containing Portugal's polyene sugar according to claim 1, it is characterised in that:Described is disease-resistant Auxiliary element in malicious composition is selected from emulsifying agent or solvent or dispersant or wetting agent or disintegrant or thickener or stabilizer Or the one or more in defoamer or filler.
  6. A kind of 6. antiviral composition containing Portugal's polyene sugar according to claim 1, it is characterised in that:Described is disease-resistant Malicious composition is used to prevent and treat brassicaceous vegetable virosis or rugose mosaic virus of potato or camellia mosaic disease or peanut stunt Or tomato virus disease or graw mold of tomato.
CN201710915949.8A 2017-09-30 2017-09-30 A kind of antiviral composition containing Portugal's polyene sugar Pending CN107549182A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710915949.8A CN107549182A (en) 2017-09-30 2017-09-30 A kind of antiviral composition containing Portugal's polyene sugar

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710915949.8A CN107549182A (en) 2017-09-30 2017-09-30 A kind of antiviral composition containing Portugal's polyene sugar

Publications (1)

Publication Number Publication Date
CN107549182A true CN107549182A (en) 2018-01-09

Family

ID=60984926

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710915949.8A Pending CN107549182A (en) 2017-09-30 2017-09-30 A kind of antiviral composition containing Portugal's polyene sugar

Country Status (1)

Country Link
CN (1) CN107549182A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110384095A (en) * 2019-08-06 2019-10-29 京博农化科技有限公司 A kind of antiviral composition containing flonicamid and Portugal's polyene sugar
CN112841229A (en) * 2021-01-27 2021-05-28 烟台恩倍得化工科技有限公司 Composition containing jerusalem artichoke leaf extracting solution and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103598197A (en) * 2013-12-05 2014-02-26 郭红甫 Plant virus disease control medicament
CN104744460A (en) * 2013-12-30 2015-07-01 南开大学 B-carboline, dihydro-B-carboline and tetrahydro-B-carboline alkaloid derivative as well as preparation method and application in aspects of plant virus prevention and cure, sterilization and insecticide

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103598197A (en) * 2013-12-05 2014-02-26 郭红甫 Plant virus disease control medicament
CN104744460A (en) * 2013-12-30 2015-07-01 南开大学 B-carboline, dihydro-B-carboline and tetrahydro-B-carboline alkaloid derivative as well as preparation method and application in aspects of plant virus prevention and cure, sterilization and insecticide

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110384095A (en) * 2019-08-06 2019-10-29 京博农化科技有限公司 A kind of antiviral composition containing flonicamid and Portugal's polyene sugar
CN112841229A (en) * 2021-01-27 2021-05-28 烟台恩倍得化工科技有限公司 Composition containing jerusalem artichoke leaf extracting solution and preparation method and application thereof
CN112841229B (en) * 2021-01-27 2021-12-28 烟台恩倍得化工科技有限公司 Composition containing jerusalem artichoke leaf extracting solution and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN106561359B (en) A method of combining prevention and treatment phytophthira pest with ladybug using pheromones compound
CN101524075A (en) Composition containing methylamine-avermetins-benzote
CN104920441A (en) Pesticide composition for preventing and treating striped flea beetles
CN106900730A (en) A kind of plant growth regualting composition
CN104488925A (en) Pesticide composition containing sterol and flonicamid
CN104488949A (en) Dinotefuran-containing insecticidal combination
CN107549182A (en) A kind of antiviral composition containing Portugal's polyene sugar
CN102239845A (en) Pesticide composition containing cytosinpeptidemycin and glucal
CN103070183B (en) High-efficiency and low-toxicity composite bird repellent containing thiram and dimethyl phthalate
CN106489956A (en) Composition pesticide and its application
CN103404530B (en) Insecticide compound and application and preparation thereof
CN102805102B (en) Disinsection combination containing fosthiazate and ryanodine receptor inhibitor insecticide
CN104322528A (en) Herbicide composition, application and medicinal preparation thereof
CN104996463B (en) A kind of corn yield increasing accelerator
CN105454238A (en) Pesticide composition containing flupyradifurone and fluopyram
CN102228025A (en) Pesticide composition containing cytosinpeptidemycin and lentinan
CN107347903A (en) A kind of composition pesticide containing cycolxylidin and matrine
CN107242238B (en) Application of isocyanuric acid in preventing and treating corn top rot
CN108651504B (en) Pesticide composition containing abamectin, fluxapyroxad and thiamethoxam
CN104770389B (en) A kind of composition pesticide for being used to prevent and treat root-knot nematode
CN104770391A (en) Pesticide composition for preventing and controlling capsicum meloidogyne
CN110384095A (en) A kind of antiviral composition containing flonicamid and Portugal's polyene sugar
CN108477183A (en) A kind of ternary weeding composition and its application
CN108576004A (en) A kind of mixed herbicide and its application containing dichloro quinolinic acid, propanil and dimethyl tetrachloride
CN108576020A (en) A kind of mixed herbicide and its application containing dichloro quinolinic acid, propanil and bentazone

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180109